Lam Research 10-K Details Governance Structure Amid $390B Valuation
The semiconductor equipment maker's annual filing outlines corporate governance provisions and board procedures, while revealing minimal detail on restructuring charges flagged in Note 20.
Corporate Governance Framework
Lam Research Corporation's latest 10-K filing provides extensive detail on the company's corporate governance structure, revealing a board size of 11 members with flexibility to adjust between seven and 15 directors by resolution. The Delaware-incorporated company maintains 4,000,000,000 authorized shares of common stock with a par value of $0.001 per share, alongside 5,000,000 preferred shares (10-K filing, 2026-08-07).
The filing details voting rights that grant common stockholders one vote per share on all matters requiring stockholder action, including director elections, though cumulative voting is not permitted. Directors may be removed with or without cause upon approval of a majority of outstanding shares entitled to vote (10-K filing, 2026-08-07).
Stockholder Rights and Access
Lam Research's bylaws establish specific thresholds for stockholder action. Special meetings may be called by stockholders who have owned at least 20% of outstanding common stock continuously for one year, subject to disclosure and procedural requirements. The company also maintains proxy access provisions requiring stockholders or groups of up to 20 stockholders to hold at least 3% of outstanding shares continuously for three years to nominate directors for inclusion in proxy statements (10-K filing, 2026-08-07).
Stockholder action by written consent is permitted without a meeting, requiring signatures from stockholders representing the minimum number of votes necessary to authorize the action if voted at a meeting where all entitled shares were present (10-K filing, 2026-08-07).
Anti-Takeover Provisions
The company remains subject to Section 203 of the Delaware General Corporation Law, which prohibits business combinations with interested stockholders owning 15% or more of voting stock for three years following their acquisition of that status, unless specific conditions are met. Lam Research has not opted out of this provision and does not currently intend to do so, a stance that "could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us" (10-K filing, 2026-08-07).
Confidentiality Framework
The filing includes a detailed confidentiality agreement template for board director candidates, requiring strict non-disclosure of proprietary information including financials, products, operations, board deliberations, and strategic plans. The agreement notably restricts directors from disclosing information to nominating stockholders or those they represent, with violations subject to injunctive relief without proof of actual damages (10-K filing, 2026-08-07).
Market Context
The filing comes as Lam Research maintains a market capitalization of approximately $390 billion with shares last closing at $311.35. MarginX data shows recent insider activity including CEO Timothy Archer exercising options and selling 30,000 shares. The company is scheduled to present at the ISIG Executive Summit EU on September 15, 2026, with Q1 2027 results expected October 23, 2026.
While the filing was categorized under "note 20: restructuring charges, net," the provided exhibits focused primarily on governance documentation rather than detailed restructuring disclosures.
This article was generated by MarginX from the 10-K filing on 2026-08-07. It is not investment advice.